pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol ESCO2   
Synonyms 2410004I17Rik, EFO2, RBS
Description establishment of sister chromatid cohesion N-acetyltransferase 2
Transcript NM_001017420   
Expression
Putative miRNA Targets on ESCO2
3'UTR of ESCO2
(miRNA target sites are highlighted)
>ESCO2|NM_001017420|3'UTR
   1 AGCTGATTTCAGTTATAAAGGAGTTACTATCTGGATAAGTTCAAAGAGCTCCTTATTATAAAATACAAACTATTTAATAT
  81 CAAAATAAAAAATACCGAGACTCACACTCATACACACACACACACACACGCACACACACATATCACAGTTTTGTTCCTTA
 161 TGAGTTGAAAAGTCAGGAATAAATTTGTTGAAAATTATCTGGGGATTCAAAGGAAAAATCTTTGGGTGATTCCCTGATTA
 241 GCACTCTGAATGTTTAATTATGAAACTTTGTAGCTATAACTGGAAAATTACCTGACTCTTTGTAAGAGTATTAAATACAA
 321 AGTGATTTTTCTCTAGAAATGTGACCTGGTCTTTTATAAAGCCCACTCTTAGACCAGGATTATCTAATGCCACATCAGAA
 401 GCAAACAGGCAAATTTAAACTTGGGCAAGTAATTTCTGTGCCCAATTTGTAAAGGGAATTCCTGAATTTTTTTTTTTTTT
 481 TAATAGAGGCATGGGTCTCACTGTGTTGCCCAGGCTGGTCTGAAACTTTTGGGCTCAAGCGATCCTCCCAAAACGCTGGG
 561 ATTACAGTCATGAGCCACCGTGCCCAGCCTAATTCCTGACTTCTCTATACAGAGTCTTCACTTGATAGGCACTCGTCTGT
 641 AGTAACTCAGTTTGAATATCTTTAGAAAATGTTTAGAATTTATTTGTAACAAGATGGTAAGGAATAAGATTATCCCATAT
 721 GCATTTCTGTAGAGCAGAATTTGATAGCTTAGTGTTCAATCTTTTTGAAAATAAATGTTTACCTGTCATCAGATTTAATT
 801 AAAATTATACTTAGTAATTGCACTATTACTTAGTTAATTTTTGTTGTATGGAAATATTGGTAGTACTACTTTGGGAACCT
 881 GTTACTGACAATTGATGTCATTAACAAAATGCCTAGTTGGATTAGATGTTTTCATTTTCTAATTTTTTGCTTGTTTAAAA
 961 TGCACCTTACTTGTTCTGAGATACCTGGCAAAAGTCTTTACAAAATGTATGGTAATAGAACCAAGGTTAGTAAATATACA
1041 TAGGCTGGTGGATGAGAGACCATGGAACTGTGTAAATACACTTAAATGTTCACACATTTTTCTAGTGTAATTCTTGGATA
1121 CTTTAAAAAGCAAAACATTGTTCAAATTGTTTTGATTCTGAAAAATCATTCAACTGCTAACTGGCAATAAGACTCTAGGC
1201 AAGTCGTTTTCCAGATTGTAATTATATGTAGAAACTATTCATCTGCATTCATTTTATTTGCCTGTAAGTTAACATGTTTC
1281 CAAAATTTAAAAGCCTGGGTCCCCAAAAGAATGTGGAAGTATTAAAATGTATGTAATTATGCAAACATTTTAATGCTATT
1361 TTCTGCACTTATTTCTTTTAAATATTTTATTTAAAATTTTTAATTAACATTTTGTTTGCTTAATGCTTTTGTTATGAATC
1441 AATTAAAATTCTTTATTTTATACAACTAAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucggcgacaGUGUGCGUGUc 5'
                     |||||||||| 
Target 5' acacacacacaCACACGCACAc 3'
114 - 135 155.00 -17.10
2
miRNA  3' agucGGCG-ACAG--UGUGCGUGuc 5'
              ::|| |||:  | |:||||  
Target 5' ttttTTGCTTGTTTAAAATGCACct 3'
943 - 967 116.00 -10.80
3
miRNA  3' agucggcgacagUGUGCGUGUc 5'
                      | || |||| 
Target 5' taaaaaataccgAGACTCACAc 3'
86 - 107 110.00 -12.72
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
362746 35 ClinVar
910875 51 ClinVar
362747 71 ClinVar
362748 76 ClinVar
362749 80 ClinVar
910876 97 ClinVar
362750 112 ClinVar
362751 112 ClinVar
362752 112 ClinVar
362753 112 ClinVar
362754 112 ClinVar
362755 112 ClinVar
362756 131 ClinVar
362757 131 ClinVar
362758 142 ClinVar
362759 156 ClinVar
362760 173 ClinVar
362761 223 ClinVar
362762 262 ClinVar
912099 267 ClinVar
912100 300 ClinVar
362763 364 ClinVar
908092 398 ClinVar
362764 426 ClinVar
362765 467 ClinVar
362766 467 ClinVar
362767 472 ClinVar
908093 492 ClinVar
362768 502 ClinVar
362769 535 ClinVar
908094 539 ClinVar
908095 698 ClinVar
910045 771 ClinVar
910046 916 ClinVar
362770 983 ClinVar
910047 1398 ClinVar
COSN30187895 55 COSMIC
COSN30131192 67 COSMIC
COSN31563546 118 COSMIC
COSN20105334 130 COSMIC
COSN19656883 131 COSMIC
COSN15665700 132 COSMIC
COSN20046181 133 COSMIC
COSN30755563 141 COSMIC
COSN20491566 471 COSMIC
COSN20833939 661 COSMIC
COSN2271166 695 COSMIC
COSN20091778 936 COSMIC
COSN5679395 1564 COSMIC
COSN5679396 1565 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs762643876 7 dbSNP
rs1205874736 12 dbSNP
rs1248234223 13 dbSNP
rs888915307 16 dbSNP
rs766717693 17 dbSNP
rs751989156 19 dbSNP
rs759971112 24 dbSNP
rs978558472 28 dbSNP
rs1439323667 30 dbSNP
rs768084748 31 dbSNP
rs182715200 35 dbSNP
rs756252880 36 dbSNP
rs1164897198 48 dbSNP
rs764124355 49 dbSNP
rs754095454 50 dbSNP
rs757615491 51 dbSNP
rs571301988 66 dbSNP
rs1411069788 68 dbSNP
rs1281882092 69 dbSNP
rs533417099 71 dbSNP
rs886062861 71 dbSNP
rs992463722 74 dbSNP
rs200615628 75 dbSNP
rs139887923 76 dbSNP
rs200314258 76 dbSNP
rs886062862 76 dbSNP
rs1314769155 80 dbSNP
rs1469440651 80 dbSNP
rs886062863 80 dbSNP
rs1183186033 82 dbSNP
rs1305611741 85 dbSNP
rs1010641907 86 dbSNP
rs1197719143 87 dbSNP
rs1292728357 94 dbSNP
rs118103454 97 dbSNP
rs1459231382 98 dbSNP
rs1343306604 109 dbSNP
rs79020291 109 dbSNP
rs1436654231 110 dbSNP
rs111607440 112 dbSNP
rs1211034437 112 dbSNP
rs1269131638 112 dbSNP
rs1320966066 112 dbSNP
rs144484866 112 dbSNP
rs1491583280 112 dbSNP
rs56062620 112 dbSNP
rs886062864 112 dbSNP
rs886062865 112 dbSNP
rs1491337355 113 dbSNP
rs1369127318 117 dbSNP
rs776760437 117 dbSNP
rs1201880504 119 dbSNP
rs1268303294 121 dbSNP
rs1429894800 122 dbSNP
rs1237022925 123 dbSNP
rs1322288091 125 dbSNP
rs969123684 125 dbSNP
rs978805676 127 dbSNP
rs1473146861 128 dbSNP
rs1415063975 129 dbSNP
rs1427392078 129 dbSNP
rs1491012950 129 dbSNP
rs1449379325 130 dbSNP
rs886062866 130 dbSNP
rs62498042 131 dbSNP
rs750245924 131 dbSNP
rs1190832679 133 dbSNP
rs199687371 133 dbSNP
rs1460268919 134 dbSNP
rs1477706403 136 dbSNP
rs1210420441 138 dbSNP
rs1171751001 140 dbSNP
rs1313625302 140 dbSNP
rs1039767444 141 dbSNP
rs200666958 142 dbSNP
rs1342784942 144 dbSNP
rs1299742449 149 dbSNP
rs993018973 152 dbSNP
rs886062867 156 dbSNP
rs1302444906 157 dbSNP
rs572397778 161 dbSNP
rs1361169091 166 dbSNP
rs539459940 173 dbSNP
rs892716002 188 dbSNP
rs1171058791 198 dbSNP
rs1448108271 199 dbSNP
rs553668388 211 dbSNP
rs573558816 218 dbSNP
rs886062868 223 dbSNP
rs1339326756 224 dbSNP
rs879614996 233 dbSNP
rs1234460660 238 dbSNP
rs755880162 243 dbSNP
rs538682688 244 dbSNP
rs1275569233 249 dbSNP
rs1203731600 251 dbSNP
rs886062869 262 dbSNP
rs1304529805 277 dbSNP
rs1243726154 279 dbSNP
rs1321093051 284 dbSNP
rs1338251546 290 dbSNP
rs1313135807 296 dbSNP
rs113728758 300 dbSNP
rs1278554877 305 dbSNP
rs1034071041 313 dbSNP
rs1381529705 319 dbSNP
rs1050127012 327 dbSNP
rs1278178303 335 dbSNP
rs1409232163 336 dbSNP
rs1443133265 346 dbSNP
rs1309975523 349 dbSNP
rs1371274309 349 dbSNP
rs1212256148 358 dbSNP
rs1368451631 362 dbSNP
rs72609983 364 dbSNP
rs544648513 368 dbSNP
rs563166470 394 dbSNP
rs576482746 395 dbSNP
rs1426286343 397 dbSNP
rs529251667 398 dbSNP
rs1405276826 404 dbSNP
rs916945773 412 dbSNP
rs72609984 426 dbSNP
rs1170508804 431 dbSNP
rs982741772 433 dbSNP
rs1253306462 447 dbSNP
rs1423960554 457 dbSNP
rs1414550675 458 dbSNP
rs909806911 462 dbSNP
rs111395487 467 dbSNP
rs1219681801 467 dbSNP
rs397787082 467 dbSNP
rs886062870 467 dbSNP
rs200753108 471 dbSNP
rs201762904 472 dbSNP
rs1358577619 473 dbSNP
rs1227979771 479 dbSNP
rs80050409 482 dbSNP
rs1298694802 483 dbSNP
rs62498043 484 dbSNP
rs921317250 489 dbSNP
rs934102759 490 dbSNP
rs149395052 492 dbSNP
rs1434010571 502 dbSNP
rs374900624 502 dbSNP
rs1459728740 505 dbSNP
rs892494950 510 dbSNP
rs551132676 518 dbSNP
rs886062871 535 dbSNP
rs1472702455 539 dbSNP
rs1022639940 541 dbSNP
rs754802033 542 dbSNP
rs35540364 547 dbSNP
rs1267913079 548 dbSNP
rs1192881443 552 dbSNP
rs564858380 555 dbSNP
rs1221044790 557 dbSNP
rs1267230800 563 dbSNP
rs377214278 567 dbSNP
rs779060596 574 dbSNP
rs1002339045 577 dbSNP
rs1034305670 578 dbSNP
rs894218929 582 dbSNP
rs1231089611 585 dbSNP
rs1330625592 601 dbSNP
rs748125804 608 dbSNP
rs1023905804 614 dbSNP
rs1363708168 622 dbSNP
rs1320293552 631 dbSNP
rs772373931 636 dbSNP
rs1173839153 648 dbSNP
rs1465073465 650 dbSNP
rs1489966406 654 dbSNP
rs1177662563 682 dbSNP
rs982868650 693 dbSNP
rs1016816951 698 dbSNP
rs1466099984 700 dbSNP
rs930323480 715 dbSNP
rs985785713 730 dbSNP
rs1245804505 732 dbSNP
rs761833073 738 dbSNP
rs1344633629 748 dbSNP
rs747030653 753 dbSNP
rs962950425 760 dbSNP
rs1377996763 762 dbSNP
rs910291460 765 dbSNP
rs773539224 771 dbSNP
rs530523680 793 dbSNP
rs1159237121 810 dbSNP
rs550621304 811 dbSNP
rs934045281 815 dbSNP
rs1402537063 823 dbSNP
rs567873959 824 dbSNP
rs1403393779 826 dbSNP
rs1427261778 829 dbSNP
rs1322600103 830 dbSNP
rs986860529 844 dbSNP
rs945235132 854 dbSNP
rs747431521 858 dbSNP
rs945365088 860 dbSNP
rs903790619 882 dbSNP
rs1000183509 890 dbSNP
rs1044120950 891 dbSNP
rs1202184604 895 dbSNP
rs771411971 898 dbSNP
rs1482127162 914 dbSNP
rs867627204 916 dbSNP
rs894497980 917 dbSNP
rs938299546 918 dbSNP
rs1376329765 924 dbSNP
rs1244598988 935 dbSNP
rs1240895792 943 dbSNP
rs1340630573 953 dbSNP
rs1335792400 956 dbSNP
rs1407403945 961 dbSNP
rs1014308191 965 dbSNP
rs1308157349 966 dbSNP
rs1024819712 978 dbSNP
rs886062872 983 dbSNP
rs1431530331 988 dbSNP
rs1388564573 989 dbSNP
rs1162429635 990 dbSNP
rs1473007029 992 dbSNP
rs1055283593 998 dbSNP
rs866477438 1004 dbSNP
rs768833011 1010 dbSNP
rs962230112 1011 dbSNP
rs1189914728 1015 dbSNP
rs1471756053 1027 dbSNP
rs368030062 1027 dbSNP
rs536880306 1030 dbSNP
rs886865941 1031 dbSNP
rs1027888640 1032 dbSNP
rs1209644959 1033 dbSNP
rs1003841984 1051 dbSNP
rs1291104286 1051 dbSNP
rs1017050847 1052 dbSNP
rs1453659017 1060 dbSNP
rs1195180356 1062 dbSNP
rs962649811 1069 dbSNP
rs1235961313 1074 dbSNP
rs1438552281 1082 dbSNP
rs547191559 1089 dbSNP
rs952328444 1095 dbSNP
rs1178642784 1097 dbSNP
rs1382129932 1102 dbSNP
rs975760260 1105 dbSNP
rs1028262472 1106 dbSNP
rs910196541 1120 dbSNP
rs955164234 1127 dbSNP
rs1405696948 1136 dbSNP
rs1471740934 1138 dbSNP
rs1392578302 1140 dbSNP
rs944381354 1148 dbSNP
rs1455830085 1153 dbSNP
rs879397555 1154 dbSNP
rs1411586162 1171 dbSNP
rs1182899815 1174 dbSNP
rs975847422 1188 dbSNP
rs986640277 1192 dbSNP
rs1162562854 1194 dbSNP
rs913949959 1196 dbSNP
rs1406865261 1204 dbSNP
rs945209972 1206 dbSNP
rs144851720 1211 dbSNP
rs979451280 1215 dbSNP
rs1447653862 1227 dbSNP
rs925303475 1228 dbSNP
rs1311495917 1236 dbSNP
rs1338757455 1240 dbSNP
rs937886770 1255 dbSNP
rs1229638937 1261 dbSNP
rs1364908781 1262 dbSNP
rs938255941 1264 dbSNP
rs1437079814 1268 dbSNP
rs1285302342 1276 dbSNP
rs1055278310 1282 dbSNP
rs1358969839 1286 dbSNP
rs1332819851 1289 dbSNP
rs1197075056 1299 dbSNP
rs918180201 1302 dbSNP
rs1255760918 1304 dbSNP
rs1318286854 1309 dbSNP
rs949520792 1327 dbSNP
rs1047886841 1328 dbSNP
rs886856166 1338 dbSNP
rs1055049317 1359 dbSNP
rs1004403495 1368 dbSNP
rs1457008356 1369 dbSNP
rs1423116343 1389 dbSNP
rs1172119074 1391 dbSNP
rs1478638055 1397 dbSNP
rs1014299923 1399 dbSNP
rs1198750044 1404 dbSNP
rs145717897 1405 dbSNP
rs1464740961 1405 dbSNP
rs1038023048 1409 dbSNP
rs1310124677 1412 dbSNP
rs993669422 1416 dbSNP
rs898132108 1419 dbSNP
rs1219372582 1422 dbSNP
rs1346948902 1427 dbSNP
rs1295326758 1429 dbSNP
rs1227329402 1431 dbSNP
rs1365697955 1434 dbSNP
rs1186822461 1440 dbSNP
rs1433131139 1449 dbSNP
rs549240800 1449 dbSNP
rs1368925380 1450 dbSNP
rs1476069100 1452 dbSNP
rs1168224229 1454 dbSNP
rs1415115697 1456 dbSNP
rs1423211702 1462 dbSNP
rs1397366822 1466 dbSNP
rs1167291566 1474 dbSNP
rs1449204896 1487 dbSNP
rs1391145392 1489 dbSNP
rs114667641 1490 dbSNP
rs1028210286 1500 dbSNP
rs1236535534 1503 dbSNP
rs187081887 1504 dbSNP
rs575568714 1506 dbSNP
rs976175526 1511 dbSNP
rs913637142 1519 dbSNP
rs1008063160 1531 dbSNP
rs1227538048 1532 dbSNP
rs966832362 1532 dbSNP
rs1395508610 1534 dbSNP
rs1020836528 1535 dbSNP
rs966808521 1536 dbSNP
rs1377165488 1547 dbSNP
rs937834657 1552 dbSNP
rs1283834995 1554 dbSNP
rs537971192 1557 dbSNP
rs1342712809 1561 dbSNP
rs1377387536 1561 dbSNP
rs192841571 1563 dbSNP
rs925407060 1564 dbSNP
rs1217215451 1565 dbSNP
rs574573140 1566 dbSNP
rs748436344 1567 dbSNP
rs990787308 1568 dbSNP
rs770009730 1571 dbSNP
rs949676301 1574 dbSNP
rs1476005430 1579 dbSNP
rs1047877946 1583 dbSNP
rs1253012596 1588 dbSNP
rs1219043201 1593 dbSNP
rs1481997052 1594 dbSNP
rs1289380309 1595 dbSNP
rs908063983 1603 dbSNP
rs942231275 1611 dbSNP
rs1038499658 1612 dbSNP
rs898253640 1616 dbSNP
rs184480668 1617 dbSNP
rs1351578929 1618 dbSNP
rs905464973 1620 dbSNP
rs891042092 1627 dbSNP
rs1300442789 1630 dbSNP
rs939615613 1632 dbSNP
rs1008179419 1638 dbSNP
rs1165993093 1643 dbSNP
rs1462682082 1653 dbSNP
rs1409396060 1657 dbSNP
rs1020784197 1661 dbSNP
rs1172886401 1669 dbSNP
rs1180744055 1672 dbSNP
rs966920452 1677 dbSNP
rs868524395 1679 dbSNP
rs1032805134 1689 dbSNP
rs1189436114 1694 dbSNP
rs569175896 1700 dbSNP
rs1265795378 1701 dbSNP
rs959486178 1702 dbSNP
rs990777464 1705 dbSNP
rs1337136098 1706 dbSNP
rs1173189962 1707 dbSNP
rs1405008530 1708 dbSNP
rs1398747601 1711 dbSNP
rs1298090683 1712 dbSNP
rs552740465 1714 dbSNP
rs970939894 1717 dbSNP
rs1443572282 1718 dbSNP
rs1385914907 1729 dbSNP
rs1402175168 1730 dbSNP
rs1297282377 1731 dbSNP
rs1173407213 1733 dbSNP
rs13266740 1737 dbSNP
rs1267975377 1738 dbSNP
rs1195199146 1741 dbSNP
rs1310035177 1742 dbSNP
rs908131538 1743 dbSNP
rs1208310563 1758 dbSNP
rs1231919331 1759 dbSNP
rs1262557417 1760 dbSNP
rs942159907 1761 dbSNP
rs1312055641 1762 dbSNP
rs973600408 1767 dbSNP
rs1304829226 1768 dbSNP
rs1236893750 1770 dbSNP
rs541322991 1776 dbSNP
rs71222516 1776 dbSNP
rs919668641 1776 dbSNP
rs763396338 1784 dbSNP
rs932425794 1786 dbSNP
rs1214450117 1790 dbSNP
rs1300495602 1793 dbSNP
rs1049412755 1801 dbSNP
rs1354830247 1806 dbSNP
rs1175474335 1807 dbSNP
rs1447626683 1810 dbSNP
rs890821243 1813 dbSNP
rs943701076 1816 dbSNP
rs559832713 1817 dbSNP
rs545242282 1820 dbSNP
rs1198745301 1821 dbSNP
rs1001065883 1824 dbSNP
rs1482979881 1828 dbSNP
rs1265568642 1829 dbSNP
rs1340730527 1830 dbSNP
rs1032215290 1833 dbSNP
rs895211610 1834 dbSNP
rs1432767907 1836 dbSNP
rs1327767337 1837 dbSNP
rs1394901475 1838 dbSNP
rs1375486126 1844 dbSNP
rs1199822168 1845 dbSNP
rs1397008680 1846 dbSNP
rs1168921123 1849 dbSNP
rs1185733631 1849 dbSNP
rs1369947979 1849 dbSNP
rs1374954494 1849 dbSNP
rs1423504534 1849 dbSNP
rs1426567567 1849 dbSNP
rs1476278873 1849 dbSNP
rs1162488098 1850 dbSNP
rs1166789307 1850 dbSNP
rs1183121323 1850 dbSNP
rs1190082698 1850 dbSNP
rs1190227454 1850 dbSNP
rs1209686289 1850 dbSNP
rs1225989915 1850 dbSNP
rs1251670950 1850 dbSNP
rs1265688936 1850 dbSNP
rs1274680422 1850 dbSNP
rs1279673517 1850 dbSNP
rs1300659701 1850 dbSNP
rs1327901140 1850 dbSNP
rs1329481506 1850 dbSNP
rs1335002650 1850 dbSNP
rs1388275576 1850 dbSNP
rs1411409997 1850 dbSNP
rs1418936428 1850 dbSNP
rs1444272954 1850 dbSNP
rs1461109509 1850 dbSNP
rs1471662712 1850 dbSNP
rs869039051 1850 dbSNP
rs1417933619 1861 dbSNP
rs1329333183 1862 dbSNP
rs1158635331 1866 dbSNP
rs1322650852 1866 dbSNP
rs1361659336 1867 dbSNP
rs200208051 1872 dbSNP
rs897841235 1872 dbSNP
rs200868899 1873 dbSNP
rs202193544 1874 dbSNP
rs200433416 1875 dbSNP
rs201729271 1876 dbSNP
rs1455704706 1877 dbSNP
rs993967417 1878 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 157570.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agUCGGCGACAGUGUGCGUGUc 5'
            | :| |  |||:|| |||| 
Target 5' --ACUCACACUCAUACACACAc 3'
1 - 20
Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
CLIP-seq Support 1 for dataset GSM714644
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000305188.8 | 3UTR | ACUCACACUCAUACACACACACACACACA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
KICH 0.54 0 0.519 0 25 Click to see details
STAD 0.446 0.01 0.401 0.01 32 Click to see details
HNSC 0.358 0.01 0.261 0.05 42 Click to see details
LIHC 0.328 0.01 0.357 0.01 49 Click to see details
UCEC 0.444 0.03 0.432 0.03 19 Click to see details
PRAD 0.243 0.04 0.112 0.22 50 Click to see details
BLCA 0.408 0.05 0.445 0.03 18 Click to see details
LUSC 0.214 0.1 0.124 0.23 38 Click to see details
BRCA 0.138 0.11 0.136 0.11 84 Click to see details
ESCA 0.344 0.15 0.300 0.19 11 Click to see details
KIRP 0.154 0.2 0.189 0.15 32 Click to see details
THCA 0.097 0.23 0.044 0.37 59 Click to see details
CHOL 0.279 0.23 0.500 0.09 9 Click to see details
PAAD 0.409 0.3 0.000 0.5 4 Click to see details
COAD -0.195 0.32 -0.095 0.41 8 Click to see details
PCPG 0.523 0.32 0.500 0.33 3 Click to see details
CESC 0.516 0.33 0.500 0.33 3 Click to see details
KIRC -0.044 0.36 -0.024 0.42 68 Click to see details
LUAD 0.004 0.5 0.063 0.42 12 Click to see details
LUAD 0.004 0.5 0.063 0.42 12 Click to see details
LUAD 0.004 0.5 0.063 0.42 12 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission